Efficacy News and Research

RSS
NanoViricides signs Research Agreement with UCSF for testing anti-HIV drug candidates

NanoViricides signs Research Agreement with UCSF for testing anti-HIV drug candidates

Tranzyme Pharma to present data on prokinetic agent TZP-101 in GI recovery at ASCRS 2010

Tranzyme Pharma to present data on prokinetic agent TZP-101 in GI recovery at ASCRS 2010

Treatment with MP-376 reduces P. aeruginosa in CF patients: Research

Treatment with MP-376 reduces P. aeruginosa in CF patients: Research

Protox announces positive top-line results from the TRIUMPH study in first quarter 2010

Protox announces positive top-line results from the TRIUMPH study in first quarter 2010

Merck, Cardiome Pharma show superiority of BRINAVESS to amiodarone injection

Merck, Cardiome Pharma show superiority of BRINAVESS to amiodarone injection

New GE SPHHS building to serve as convening place for public health leaders

New GE SPHHS building to serve as convening place for public health leaders

New intervention method reduces self-stigma in mentally-ill patients

New intervention method reduces self-stigma in mentally-ill patients

Lotus Pharmaceuticals first-quarter net income up 38%

Lotus Pharmaceuticals first-quarter net income up 38%

Agronomic practices can increase cancer-preventive phytochemicals in broccoli and tomatoes

Agronomic practices can increase cancer-preventive phytochemicals in broccoli and tomatoes

Amgen submits BLA for denosumab subcutaneous RANK Ligand inhibitor

Amgen submits BLA for denosumab subcutaneous RANK Ligand inhibitor

FDA assigns Cadence Pharmaceuticals' OFIRMEV NDA new PDUFA action date

FDA assigns Cadence Pharmaceuticals' OFIRMEV NDA new PDUFA action date

BioSante Pharmaceuticals first-quarter net loss increases to $10.5 million

BioSante Pharmaceuticals first-quarter net loss increases to $10.5 million

Hana Biosciences reports $5.5 million net loss for first-quarter 2010

Hana Biosciences reports $5.5 million net loss for first-quarter 2010

Convergent procedure promising for longstanding persistent atrial fibrillation

Convergent procedure promising for longstanding persistent atrial fibrillation

SPIROCOR's RSR non-invasively measures presence of significant coronary artery disease

SPIROCOR's RSR non-invasively measures presence of significant coronary artery disease

Inhibitex reports net loss of $4.8M for first-quarter 2010

Inhibitex reports net loss of $4.8M for first-quarter 2010

FREEDOM trial results to be presented at Heart Rhythm 2010

FREEDOM trial results to be presented at Heart Rhythm 2010

International study to test effectiveness of celecoxib in preventing growth of precancerous polyps

International study to test effectiveness of celecoxib in preventing growth of precancerous polyps

GRNCM1 do not cause cardiac arrhythmias after transplantation: Preclinical study

GRNCM1 do not cause cardiac arrhythmias after transplantation: Preclinical study

DMC recommends Celsion to continue enrollment in ThermoDox clinical study for primary liver cancer

DMC recommends Celsion to continue enrollment in ThermoDox clinical study for primary liver cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.